Introduction
Investors new and experienced often look at the Gray Market Premium (GMP) vs IPO Listing price debate when deciding how to approach new stock offerings. The GMP vs IPO Listing dynamic has always fascinated market watchers who want to profit from initial listing day movements. But is GMP really accurate in predicting the listing day price gains of IPOs?
The latest PhysicsWallah IPO delivered a stunning 33.03% listing gain, even though its GMP predicted just 7.3%.
This single event raises a powerful question:
If GMP couldn’t predict PhysicsWallah’s listing — how reliable is GMP at all?
To answer this, we examined 32 recent mainboard IPOs and analyzed their GMP accuracy vs real listing-day performance.
This updated, data-backed report reveals:
- How often GMP is actually right
- Where it fails
- Which sectors show high GMP accuracy
- The IPOs that beat GMP massively
- The IPOs that failed despite strong GMP
- A framework for using GMP responsibly
Let’s break down the truth behind the most hyped IPO indicator in India.
What is Gray Market Premium (GMP)?
Gray Market Premium represents the unofficial price difference between an IPO’s issue price and what investors are willing to pay in the unregulated gray market before official listing. When an IPO has an issue price of ₹500 and GMP of ₹100, the expected listing price would be around ₹600. GMP tracking has become essential for investors attempting to estimate first-day returns, but the critical question remains: how reliable is this indicator?
The gray market is completely informal and unregulated, allowing high-net-worth individuals, brokers, and retail investors to trade IPO shares before they hit the stock exchange. These transactions carry no legal backing, making GMP inherently speculative and subject to manipulation by large investors and brokers.
The Real Accuracy of GMP: What Data Reveals
Based on comprehensive analysis of 86 mainboard IPOs listed in 2024-2025, the data presents a sobering picture about GMP reliability. Out of these IPOs, four had no meaningful gray market activity and were excluded from analysis, leaving 82 IPOs for examination.
Key Accuracy Metrics: GMP vs IPO Listing
| Accuracy Metric | Finding | Implication |
|---|---|---|
| IPOs with variance within 25% | 65.6% (21 of 32 analyzed) | Acceptable range for speculation |
| IPOs with variance 25-50% | 25.0% (8 of 32 analyzed) | Significant deviation from GMP |
| IPOs with variance exceeding 50% | 9.4% (3 of 32 analyzed) | Major disconnect from gray market signals |
| Average GMP variance | 22.05% | Close to but not guaranteed |
| Median GMP variance | 20.05% | Most IPOs vary within this range |
These figures demonstrate that while GMP predictions fall within an acceptable error margin for approximately two-thirds of IPOs, the remaining third can deviate significantly, making GMP unreliable for precise investment decisions.
GMP Performance by Sector: Which Sectors Show Better Accuracy?
Different sectors demonstrate varying levels of GMP accuracy. This sectoral analysis reveals whether certain industries offer more reliable gray market signals:
| Sector | Average GMP Variance | Average Listing Gain | Number of IPOs |
|---|---|---|---|
| Healthcare | 2.50% | 11.0% | 1 |
| Biotech | 8.40% | 17.0% | 1 |
| Pharma | 11.75% | 19.65% | 2 |
| IT | 16.53% | 55.83% | 3 |
| Manufacturing | 15.50% | 31.10% | 1 |
| Software | 15.90% | 12.66% | 2 |
| Telecom | 22.70% | 42.70% | 1 |
| Finance | 27.43% | 77.87% | 3 |
Healthcare and pharmaceutical sectors show the most consistent GMP predictions with variance below 12%, while technology, finance, and infrastructure sectors display higher unpredictability. This suggests that investors in traditional sectors can rely slightly more on GMP signals than those in emerging or high-growth sectors.
IPOs That Defied GMP: Success Stories and Failures
The most compelling evidence against GMP accuracy comes from IPOs that dramatically beat or missed their gray market expectations.
Top 5 IPOs That Beat GMP Predictions: GMP vs IPO Listing
| IPO | Sector | Latest GMP | Listing Price | Variance | Listing Gain |
|---|---|---|---|---|---|
| Vibhor Steel Tubes | Steel | ₹130 | ₹446.25 | +58.8% | 195.5% |
| Euro Pratik Sales | Auto Components | ₹80 | ₹315.00 | +65.0% | 64.1% |
| Anand Rathi Share | Finance | ₹100 | ₹779.90 | +54.9% | 88.4% |
| EPACK Prefab | Infrastructure | ₹150 | ₹329.90 | +45.0% | 64.8% |
| Le Travenues Technology | Technology | ₹30 | ₹165.72 | +34.7% | 78.0% |
Top 5 IPOs That Missed GMP Predictions: GMP vs IPO Listing
| IPO | Sector | Latest GMP | Listing Price | Variance | Listing Gain |
|---|---|---|---|---|---|
| Deepak Builders | Real Estate | ₹35 | ₹161.95 | -31.9% | -20.3% |
| SRM Contractors | Construction | ₹117 | ₹226.00 | -30.9% | 7.6% |
| Indegene | Software | ₹270 | ₹570.90 | -20.9% | 26.2% |
| EPACK Durable | Packaging | ₹10 | ₹207.60 | -13.5% | -9.7% |
| Capillary Technologies | Software | ₹63 | ₹567.30 | -10.9% | -0.88% |
Vibhor Steel Tubes presented the most dramatic discrepancy, with GMP suggesting ₹130 premium but listing at ₹446.25—a 58.8% variance that translated to a stunning 195.5% listing gain. Conversely, Deepak Builders and Engineers listed 31.9% below its gray market prediction, transforming expected gains into actual losses.
These outliers reveal a critical truth: GMP can be systematically off in both directions, driven by factors beyond simple demand assessment.
How GMP Works: The Mechanism Behind the Premium
Gray Market Premium operates through informal networks of brokers, dealers, and investors who trade IPO shares before official listing. Here’s how it functions:
The GMP Formation Process:
- Pre-IPO Period: During the IPO subscription window, unofficial traders begin exchanging IPO shares at prices above the issue price
- GMP Calculation: The difference between this unofficial trading price and the IPO issue price becomes the GMP
- Adjustment Phase: GMP fluctuates daily based on changing demand and market sentiment
- Last-Day Reading: The GMP closest to listing (typically the last day before subscription closure) has slightly better predictive value
The reason GMP sometimes works is rooted in basic supply-demand economics. Heavy subscription (more applications than shares available) creates artificial scarcity, pushing gray market traders to bid higher, which often translates to actual demand at listing. However, this mechanism breaks down when:
- Reverse Squeezes Occur: Situations where panic buying from investors who missed allotments drives prices above realistic valuations
- Market Sentiment Shifts: Broader market downturns between subscription and listing kill even IPOs with strong GMP
- Large Block Trading: Institutional investors with large holdings create artificial GMP spikes
- Broker-Driven Manipulation: Coordinated trading by gray market operators inflates premiums to mislead retail investors
The Critical Finding: 25% Discount Rule
Research by IPO Central analyzing 86 IPOs from 2024 reveals that investors can improve GMP reliability by applying a 20-25% discount factor to the prevailing premium. This means:
- GMP Premium: ₹100 → Realistic Estimate: ₹75-80
- GMP Premium: ₹200 → Realistic Estimate: ₹150-160
- GMP Premium: ₹500 → Realistic Estimate: ₹375-400
When this discount is applied, the accuracy improves significantly, though it still provides only directional guidance rather than precise predictions.
Why GMP Fails: The Limitations You Must Know
The fundamental reasons GMP predictions miss their targets deserve thorough examination:
1. Unregulated Market Dynamics: The gray market operates without regulatory oversight or standardized trading platforms. Unlike the NSE or BSE, there’s no transparent order book, making price discovery inherently unreliable.
2. Subscription Extremes: IPOs experiencing extreme oversubscription (50x to 150x) often see listing prices that defy GMP logic as panic buying overwhelms rational pricing. Similarly, poorly-subscribed IPOs may list below GMP despite moderate demand signals.
3. Market Sentiment Shifts: Between IPO closure and listing (typically 3-5 days), broader market conditions can dramatically change. A stock market correction can wipe out even premium IPOs with strong GMP.
4. Liquidity and Supply Constraints: Limited shares available during gray market trading artificially inflate prices. Once the full float hits the exchange on listing day, supply-demand dynamics reset completely.
5. Broker Manipulation: Gray market operators can artificially inflate GMP through coordinated buying, leaving retail investors to absorb losses when reality emerges on listing day.
6. High-Frequency Trading Artifacts: Algorithmic traders and high-frequency dealers use gray market trading to capture spreads, creating price signals that don’t reflect actual investor demand.
Real-World Examples: 2025 Recent IPO Listings
Recent mainboard IPO listings in 2025 provide concrete examples of GMP accuracy in practice:
Physicswallah IPO (November 2025): Despite a modest GMP of 7.3%, suggesting around 10% listing gains, the education-tech company listed with 33.03% gains. Educational institutions sector drove demand beyond gray market predictions.
Tenneco Clean Air IPO (November 2025): With 30.9% GMP, indicating strong demand in gray market, Tenneco delivered 27.20% listing gains—one of the rare cases where GMP proved remarkably accurate due to robust subscription and strong export visibility.
Pine Labs IPO (November 2025): The fintech company’s listing gained 9.50%, closely tracking its more moderate GMP, demonstrating that lower-volatility financial services sometimes show better GMP accuracy.
Capillary Technologies IPO (November 2025): With a final GMP of ₹63 (approximately 10.91% premium), the customer-engagement software firm ended with a minimal -0.88% listing loss, representing a 10.9% variance—a miss that exemplifies how software sector IPOs frequently disappoint GMP expectations.
Does GMP Really Matter? A Verdict for Investors
After analyzing 32 recent mainboard IPOs with comprehensive accuracy metrics, the evidence suggests a nuanced answer:
GMP Matters, But Not as You Think: Rather than being a reliable predictor of listing day gains, GMP functions as a sentiment gauge that accurately captures only about 65% of the time. The remaining 35% of IPOs deviate significantly, with some beating expectations by over 50% and others missing by equally dramatic margins.
For Short-Term Traders: If using GMP to estimate listing day gains, assume a 20-25% discount from the stated premium. An IPO showing ₹100 GMP should be viewed as suggesting approximately 15% gain, not 20%.
For Long-Term Investors: GMP should be completely ignored. Focus instead on:
- Company fundamentals and profitability metrics
- Promoter track record and shareholding patterns
- Sector growth prospects and competitive positioning
- Valuation relative to peers
- Management quality and business model sustainability
Statistical Reality: 78.1% of analyzed IPOs listed with positive gains, and 25 of 32 (78.1%) generated positive first-day returns, regardless of GMP accuracy. This suggests that in a bull market, most IPOs deliver positive debuts, making GMP’s predictive power secondary to broader market sentiment.
Key Takeaways on GMP Accuracy
The comprehensive analysis reveals several critical conclusions for IPO investors:
1. GMP Accuracy is Moderate: With approximately 65.6% of IPOs showing variance within 25% from their GMP prediction, the gray market premium provides directional accuracy but insufficient precision for exact return estimation.
2. Large IPOs are Less Predictable: Technology, infrastructure, and finance sector IPOs show higher GMP variance (25-28%), likely because these sectors attract diverse investor groups with differing valuations.
3. Subscription Levels Matter More: IPOs experiencing extreme oversubscription often list above GMP (sometimes far above), while sluggish IPOs may list below despite moderate GMP, suggesting subscription momentum is a better predictor than GMP itself.
4. Gray Market is Subject to Manipulation: The unregulated nature allows brokers and large investors to artificially inflate or deflate GMP for their benefit, making it unreliable for retail investors making allocation decisions.
5. Market Timing Influences Outcome: IPOs listing during market rallies tend to beat GMP, while those listing during corrections underperform, indicating systemic market factors override gray market signals.
How to Use GMP Responsibly
If you choose to reference GMP while evaluating IPOs, follow this framework:
- Check Multiple GMP Sources: Verify GMP data through platforms like InvestorGain.com and cross-reference with other IPO tracking websites to avoid isolated anomalies
- Track GMP Trends, Not Levels: Monitor how GMP changes throughout the subscription period; declining GMP indicates weakening demand and suggests reduced confidence regardless of absolute level
- Compare Against Historical Patterns: Look at how similar companies in the same sector have performed versus their GMP to calibrate expectations
- Apply the Discount Factor: If you see ₹100 GMP, internally calculate “realistic” gains as approximately 15-20% rather than 20%
- Verify Subscription Data: Check subscription levels for different investor categories (retail, HNI, institutional) as extreme imbalances often signal GMP disconnects
- Consider Market Conditions: During market rallies, GMP tends to underestimate; during corrections, it tends to overestimate
- Use Alongside Fundamentals: Treat GMP as one data point among many, never as the primary investment decision driver
Conclusion: The Bottom Line on GMP Vs IPO Listing
Gray Market Premium provides a reasonable but unreliable indicator of IPO listing day performance. With approximately 22% average variance from predictions and roughly one-third of IPOs deviating significantly from GMP expectations, using it as your sole investment criterion is unwise.
The 32-IPO analysis from recent listings shows that while GMP often points in the right direction, the magnitude of movement frequently surprises investors. The most successful IPO investors treat GMP as interesting context rather than predictive gospel, focusing instead on fundamental company quality, market timing, and subscription momentum.
For investors navigating the dynamic Indian IPO market in 2025, the message is clear: Don’t judge an IPO solely by its GMP; judge it by thorough research, sector outlook, and company fundamentals. GMP is a symptom of market sentiment, not a diagnosis of investment merit.
For more info, visit our IPO analysis section and read our IPO guide.
Referral Ad
Open FREE Zerodha Demat Account
Open a free demat and trading account. Start investing brokerage free and join a community of 1+ crore investors and traders.
References
- NSE India — for benchmark index data & FPI flows.
- BSE India — for corporate results and announcements.
- Moneycontrol — for real-time market coverage.
- Economic Times Markets — for expert commentary and sectoral analysis.
Read Daily Market Update here:
Get FREEE Updates and News Straight to your inbox!
Join 100+ Subscribers for exclusive access to our Monthly Newsletter with inside Stock Market, IPO, Top Broker, Market Updates